← Back to headlines
Bayer to Acquire Perfuse Therapeutics in $2.45 Billion Deal
Bayer has announced its intention to acquire Perfuse Therapeutics in a $2.45 billion deal, a move expected to bolster its ophthalmology pipeline.
6 May, 09:03 — 6 May, 09:03
Sources
Showing 1 of 1 sources
